Navigation Links
Nyer Medical Group Completes Acquisition of Minority Interest in Pharmacy Chain Subsidiary; Former Minority Shareholders Invest in Nyer Medical Group and Sign 3-Year Employment Agreements
Date:2/15/2008

Pharmacy Subsidiary opens New Pharmacy in Southborough MA and agrees to

open Second Pharmacy in Lynn MA

BANGOR, Maine, Feb. 15 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER) today announced that it has acquired the remaining 20% interest in its pharmacy chain subsidiary, D.A.W., Inc. d/b/a Eaton Apothecary on February 4, 2008. As consideration for the minority interest, the former minority shareholders received a cash payment of $1.75 million, convertible notes totaling $1.5 million bearing interest at 8% maturing in 3-years, a note for $350,000 bearing interest at 7% maturing in 5-years and newly issued class B-2 preferred stock with a mandatory conversion feature in 3 years and possessing of 4 million voting shares. In contemporaneous transactions, the former minority shareholders acquired 597,826 shares of the company's common stock from Nyle International for $1.1 million while the company acquired all of its outstanding shares of Class A and B preferred stock in exchange for a $400,000 promissory note bearing interest at a rate of 7% per annum maturing in 5 years. The company immediately retired the preferred shares. The pharmacy chain's primary supplier funded the cash portion of the transaction through an extension of payment terms.

Through the completion of the aforementioned transactions, the former minority shareholders now control approximately 58% of the voting power of Nyer. In a related series of events, Karen Wright resigned her position as president and CEO of Nyer while continuing as Secretary, Treasurer and Vice- President of Finance. Additionally, she, Dr. Kenneth Nyer and Mr. Donald Lewis resigned their board positions. Mark Dumouchel, president of the pharmacy chain subsidiary was voted company CEO and President, and additionally will fill the board position vacated by Dr. Kenneth Nyer. David Dumouchel, a Vice-President of the pharmacy subsidiary and brother of Mark Dumouchel, was appointed to fill the board position vacated by Karen Wright. The two Dumouchels, along with two of the remaining minority shareholders and the spouse of the third minority shareholder, signed three-year employment agreements. Mark Dumouchel will remain as President of the pharmacy segment and will serve as President and CEO of Nyer. The other individuals will serve as managers of the pharmacy segment in varying capacities.

"We are eager to be solely focused on the growth opportunities available to the company and to move forward on behalf of the company's shareholders deriving the full value inherent in the company," stated President and CEO, Mark Dumouchel. "Going forward, the company will seek to enhance its position within niche markets that are developing and expanding as a result of the aging baby-boomer population. We will also seek out opportunities in contiguous markets that will enhance the company's profitability," Dumouchel stated.

The company further announced that its pharmacy subsidiary opened its twenty-first location in December in Southborough, Massachusetts and has agreed to open its twenty-second location in Lynn Massachusetts, in March of this year. "The Southborough location will fill a void within an affluent suburb of Boston as there are no competing pharmacies within a 4 plus mile radius while the Lynn location will be opened in close collaboration with the Lynn Community Health Center and represents further expansion by the company within the Public Health Services' Section 340B purchasing program," stated company CEO, Mark Dumouchel. "Each of the two new locations represents a synergistic opportunity for the company going forward," Dumouchel stated. "We are pleased with both opportunities and the added value they represent for shareholders."

Nyer Medical Group, Inc. is a holding company that, through its subsidiaries, operates pharmacies in the greater Boston area and a medical products business that distributes and markets medical equipment and supply products to hospitals, physicians and nursing homes using relationship-based telemarketing, direct sales personnel, catalogs and the Internet. These orders are filled by the company's distribution centers located in New England and South Florida.

For further information contact Mark Dumouchel (508) 429-8506 ext 16

Safe Harbor under the Private Securities Litigation Reform Act of 1995 This press release may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. All statements in this release that are not historical facts are forward-looking statements and are subject to risks and uncertainties, including enhancing the company's profitability. Among the factors that change the anticipated results are changes in the capital equity markets. Nyer does not undertake any obligation to update these forward-looking statements.


'/>"/>
SOURCE Nyer Medical Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
Breaking Medicine Technology: